当前位置:首页 - 行情中心 - 泰格医药(300347) - 财务分析 - 资产负债表

泰格医药

(300347)

  

流通市值:287.17亿  总市值:438.26亿
流通股本:5.60亿   总股本:8.55亿

资产负债表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
流动资产:
  货币资金2,102,880,2762,099,264,132.822,168,149,586.041,777,491,807.26
  交易性金融资产15,454,600.3627,806,525.0332,707,444.1759,459,161.12
  应收票据及应收账款1,429,256,312.591,353,997,046.431,369,518,281.431,412,732,524.78
  其中:应收票据5,440,896.9222,260,839.219,275,011.927,004,266.15
        应收账款1,423,815,415.671,331,736,207.221,360,243,269.511,405,728,258.63
  应收款项融资816,415.293,809,747.41,239,061.493,953,348.43
  预付款项182,020,443.18157,272,413.74121,535,508.28122,972,634.86
  其他应收款合计118,443,336.33103,362,007.4109,453,807.44109,395,716.23
  存货62,996,166.2365,619,741.155,950,637.8841,501,796.41
  合同资产2,730,653,878.932,721,740,798.392,708,380,363.282,584,975,822.49
  其他流动资产194,103,189.1975,461,550.6762,314,633.6464,713,930.31
  流动资产合计6,836,624,618.16,608,333,962.986,629,249,323.656,177,196,741.89
非流动资产:
  长期股权投资4,624,765,397.414,358,850,805.854,439,142,469.734,498,839,308.43
  其他权益工具投资6,617,892.865,812,568.736,653,545.58,545,553.12
  其他非流动金融资产9,698,181,719.699,612,948,804.6910,284,046,755.289,840,237,126.48
  投资性房地产15,563,627.2713,861,426.8214,356,069.1415,388,440.06
  固定资产1,157,233,461.021,172,680,165.81,163,500,457.011,188,210,085.11
  在建工程77,932,306.7579,293,924.37132,713,179.56110,604,207.57
  使用权资产332,225,909.08336,336,396.88384,499,710.95408,905,731.66
  无形资产220,821,074.59235,775,056.6254,005,873.05276,312,305.22
  商誉3,457,049,465.573,454,545,054.583,484,849,857.413,520,215,745.68
  长期待摊费用174,598,965.04177,844,712.01179,801,217.93189,282,477.31
  递延所得税资产152,833,193.31149,058,870.08150,609,263.1145,119,832.23
  其他非流动资产1,231,367,406.271,687,852,740.161,677,057,078.491,979,937,603.41
  非流动资产合计21,149,190,418.8621,284,860,526.5722,171,235,477.1522,181,598,416.28
  资产总计27,985,815,036.9627,893,194,489.5528,800,484,800.828,358,795,158.17
流动负债:
  短期借款265,266,196.31245,644,743.91404,947,667.71511,020,767.84
  应付票据及应付账款337,468,812.03320,761,169.04336,565,849.72371,118,244.78
  其中:应付票据3,239,727.723,239,727.726,090,170.145,889,386.05
        应付账款334,229,084.31317,521,441.32330,475,679.58365,228,858.73
  合同负债1,436,359,968.221,354,710,037.31,251,417,957.211,079,154,504.24
  应付职工薪酬302,566,079.19240,585,573.05356,208,538.15327,858,233.53
  应交税费112,447,498.7894,817,105.19205,938,183.63231,541,815.12
  其他应付款合计66,659,389.67193,280,248.5684,244,049.2374,461,840.09
  其中:应付利息451,840.142,453,240.561,567,912.21,388,432.36
        应付股利226,842.1107,547,867.662,122,515.763,752,582.61
  一年内到期的非流动负债121,268,436.22164,431,909.14191,317,991.14201,525,360.57
  其他流动负债46,311,602.5544,513,060.2949,039,050.7238,793,286
  流动负债合计2,688,347,982.972,658,743,846.482,879,679,287.512,835,474,052.17
非流动负债:
  长期借款1,423,866,310.521,538,813,310.47691,647,009.48510,560,589.95
  应付债券101,915,495.5588,240,090.288,809,667.9392,473,704.64
  租赁负债305,468,348.86306,674,720.06344,569,247.44360,616,779.32
  长期应付款11,980,00011,980,00011,980,000102,518,850
  长期应付职工薪酬10,313,395.7210,033,512.5310,172,418.9810,897,307.43
  递延收益15,036,273.8615,398,772.4615,776,161.316,408,677.01
  递延所得税负债167,591,399.58171,744,272.28192,930,835.09173,420,006.7
  非流动负债合计2,036,171,224.092,142,884,6781,355,885,340.221,266,895,915.05
  负债合计4,724,519,207.064,801,628,524.484,235,564,627.734,102,369,967.22
所有者权益(或股东权益):
  实收资本(或股本)861,026,050861,026,050861,026,050861,026,050
  资本公积10,603,057,808.8810,580,069,339.1510,556,514,520.7410,584,957,589.83
  减:库存股1,124,475,008.611,124,475,008.61300,069,890300,069,890
  其他综合收益-81,317,118.25-77,700,568.81-6,635,437.9957,068,522.37
  盈余公积436,529,393.76436,529,393.76436,529,393.76436,529,393.76
  未分配利润8,942,879,242.178,801,768,375.139,369,037,969.949,319,994,848.81
  归属于母公司股东权益合计19,637,700,367.9519,477,217,580.6220,916,402,606.4520,959,506,514.77
  少数股东权益3,623,595,461.953,614,348,384.453,648,517,566.623,296,918,676.18
  股东权益合计23,261,295,829.923,091,565,965.0724,564,920,173.0724,256,425,190.95
  负债和股东权益合计27,985,815,036.9627,893,194,489.5528,800,484,800.828,358,795,158.17
公告日期2026-10-302026-08-292026-04-292026-03-31
审计意见(境内)标准无保留意见
TOP↑